Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 ...

The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung ...

Following promising phase 1 data, ISB 2001 has gained fast track designation from the FDA for the treatment of ...

This valuable study provides insights into a key question in comparative neuroanatomy and development. The authors provide evidence of the role for a particular micro-RNA in regulating the development ...

Capricor Therapeutics saw its shares fall 13% by the end of trading Monday as its investigational cell therapy deramiocel for ...

AstraZeneca’s Calquence plus chemoimmunotherapy approved in EU to treat adult patients with previously untreated mantle cell lymphoma: Cambridge, UK Wednesday, May 7, 2025, 09:0 ...

A novel off-the-shelf CAR NK therapy using logic gates has shown complete remissions in relapsed AML patients, according to ...

During a live event, Daniel M. Geynisman, MD, and participants discussed which efficacy end points they value and how they ...

OncoCyte Corporation’s OCX share price has surged by 5.11%, which has investors questioning if this is right time to sell.

Prediabetes silently harms your heart, brain, eyes and more long before diabetes develops. Learn the hidden dangers of this ...

Stanford Cardiovascular Institute researchers have discovered a mechanosensing-based approach that reduces cardiac fibrosis ...